Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NRG-GY020)

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date6/22/20 → …